• Ghizlene Lahlou, Yann Nguyen, Francesca Yoshie Russo, Evelyne Ferrary, Olivier Sterkers, and Daniele Bernardeschi.
• AP-HP, Pitie-Salpetriere Hospital, Otology, Auditory Implants and Skull Base Surgery Department, Paris, France.
• Otolaryngol Head Neck Surg. 2016 Nov 1; 155 (5): 850-855.

ObjectiveFacial nerve tumors are rare lesions mostly located in the geniculate ganglion. This study aims to compare those tumors limited to the geniculate ganglion in terms of clinical features and postoperative outcomes.Study DesignCase series with chart review.SettingsUniversity tertiary reference center.Subjects And MethodsMedical charts were reviewed for 17 patients who had surgery for geniculate ganglion tumor removal (10 hemangiomas, 6 schwannomas, 1 meningioma). Hemangiomas and schwannomas were compared for preoperative facial nerve function, hearing, tumor size, and postoperative outcomes.ResultsFacial palsy was observed in all cases. Regarding the preoperative facial nerve function, severe facial palsy (House-Brackmann grades V and VI) was present in 70% of cases for hemangiomas and for no case of schwannoma (P = .01), although hemangiomas were significantly smaller tumors (P = .01). Hearing loss was observed in 4 cases (23.5%) and was related to tumor volume (P < .0001). A complete excision was achieved in all cases, and a facial nerve graft was performed immediately after interruption in 16 patients (94%). Postoperative facial nerve function was improved or stabilized in 94% of cases. A preoperative House-Brackman grade VI was shown as a negative factor for postoperative facial nerve function.ConclusionsDifferences in clinical presentations could help in establishing the good therapeutic option depending on the tumor type. Surgery, when indicated, is safe and effective, and postoperative outcomes are not related to tumor type.© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

27 keywords...

hide…